Program
Lamotrigine
Also written as “lamotrigine”, “Lamotrigine Tablets 25 mg” and “Lamictal”.
Its studies are mostly in Epilepsy · Bipolar Disorder · Epilepsy, Tonic-Clonic · Epilepsies, Partial · Schizophrenia, led by 9 companies.
Drug pageLamotrigine: every studyMany companies study it; this page follows only the 54 they lead. All 137 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| GlaxoSmithKlineits history only | 330 open or running | phase 4since Aug 14, 2002 | Aug 14, 2002 | none ahead |
| Dr. Reddy's Laboratoriesits history only | 80 open or running | phase 1since May 26, 2010 | May 26, 2010 | none ahead |
| Teva Pharmaceutical Industriesits history only | 40 open or running | phase 1since Jan 30, 2009 | Jan 30, 2009 | none ahead |
| IPCA Laboratoriesits history only | 20 open or running | phase 1since Jun 11, 2012 | Jun 11, 2012 | none ahead |
| Torrent Pharmaceuticalsits history only | 20 open or running | phase 1since Jul 13, 2009 | Jul 13, 2009 | none ahead |
| Viatrisits history only | 20 open or running | phase 1since Mar 30, 2008 | Mar 30, 2008 | none ahead |
| Alembic Pharmaceuticalsits history only | 10 open or running | phase 1since Jan 9, 2018 | Jan 9, 2018 | none ahead |
| Desitin Arzneimittelits history only | 10 open or running | phase 1since Dec 12, 2023 | Dec 12, 2023 | none ahead |
| Pharmtechnologyits history only | 10 open or running | phase 1since Mar 29, 2019 | Mar 29, 2019 | none ahead |
Also a collaborator on its studies: BioPharma Services.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of every company. Pick one to see its own:
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 33 studies since Aug 14, 2002.
- May 26, 2010Dr. Reddy's Laboratories’ first studies: 2 phase 1 studies in HealthyNew to Dr. Reddy's LaboratoriesDr. Reddy's Laboratories · NCT01131975, NCT01131949
- May 12, 2011Phase 1 study in EpilepsyGlaxoSmithKline · NCT01357902 · 24 enrolled · Hong Kong
- Sep 1, 20112 phase 3 studies in EpilepsyGlaxoSmithKline · NCT01431976, NCT01431963
- Jan 17, 20122 phase 1 studies in HealthyDr. Reddy's Laboratories · NCT01513720, NCT01513681
- May 17, 2012Phase 3 study in Bipolar DisorderGlaxoSmithKline · NCT01602510 · 265 enrolled · China
- Jun 11, 2012IPCA Laboratories’ first studies: 2 phase 1 studiesNew to IPCA LaboratoriesIPCA Laboratories · NCT01618825, NCT01618799
- Jun 13, 2013Phase 1 study in EpilepsyGlaxoSmithKline · NCT01879423 · 24 enrolled · China
- Jun 25, 20134 phase 1 studies in HealthyDr. Reddy's Laboratories · NCT01888263, NCT01888250, NCT01888757 and 1 more
- Feb 13, 2014Phase 1 study in EpilepsyGlaxoSmithKline · NCT02064465 · 138 enrolled · China
- Mar 27, 2014Phase 4 study in EpilepsyGlaxoSmithKline · NCT02100644 · 33 enrolled · Japan
- Jul 30, 2015Phase 1 study in Bipolar DisorderGlaxoSmithKline · NCT02513654 · 16 enrolled · China
- Jan 9, 2018Alembic Pharmaceuticals’ first study: phase 1 study in BioequivalenceNew to Alembic PharmaceuticalsAlembic Pharmaceuticals · NCT05145608 · 22 enrolled · Canada
- Mar 29, 2019Pharmtechnology’s first study: phase 1 study in Healthy AdultsNew to PharmtechnologyPharmtechnology · NCT03898011 · 28 enrolled · Russian Federation
- Dec 12, 2023Desitin Arzneimittel’s first study: phase 1 study in FastingNew to Desitin ArzneimittelDesitin Arzneimittel · NCT06199791 · 24 enrolled · Canada
TargetBeta
“Sodium channel alpha subunit blocker”ChEMBL 37, by rule
Other programs on the same 10 targets
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Lidocainerule | Keenova Therapeutics | phase 4 | 63 |
| Carbamazepinerule | grin-therapeutics-inc | phase 4 | 21 |
| Dronedaronerule | Sanofi | phase 4 | 18 |
| chloroprocainerule | sintetica-sa | phase 4 | 8 |
| Riluzolerule | Sanofi | phase 4 | 6 |
| Prilocainerule | Haisco Pharmaceutical Group | phase 4 | 2 |
| Carticainerule | Laboratoires Thea | phase 4 | 1 |
| Ropivacainerule | painreform-ltd | phase 3 | 17 |
| Quinidinerule | Otsuka | phase 3 | 17 |
| Phenytoinrule | Viatris | phase 3 | 10 |
| rufinamiderule | Eisai | phase 3 | 7 |
Studies
All 54 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT06199791Fasting · Canada | 1 | Completed | Desitin Arzneimittel | May 9, 2023 | 24 |
| NCT03898011Healthy Adults · Russian Federation | 1 | Completed | Pharmtechnology | May 4, 2019 | 28 |
| NCT05145608Bioequivalence · Canada | 1 | Completed | Alembic Pharmaceuticals | Feb 21, 2018 | 22 |
| NCT02513654Bipolar Disorder · China | 1 | Completed | GlaxoSmithKline | Nov 11, 2015 | 16 |
| NCT02100644Epilepsy · Japan | 4 | Completed | GlaxoSmithKline | May 11, 2015 | 33 |
| NCT02064465Epilepsy · China | 1 | Completed | GlaxoSmithKline | Jul 8, 2014 | 138 |
| NCT01888757Healthy · India | 1 | Completed | Dr. Reddy's Laboratories | Sep 2010 | 62 |
| NCT01888731Healthy · India | 1 | Completed | Dr. Reddy's Laboratories | Aug 2010 | 62 |
| NCT01888263Healthy · India | 1 | Completed | Dr. Reddy's Laboratories | Aug 2010 | 32 |
| NCT01888250Healthy · India | 1 | Completed | Dr. Reddy's Laboratories | Aug 2010 | 36 |
| NCT01879423Epilepsy · China | 1 | Completed | GlaxoSmithKline | Jun 6, 2013 | 24 |
| NCT01618825Lecithin Cholesterol Acyltransferase Deficiency · India | 1 | Completed | IPCA Laboratories | May 2012 | 28 |
| NCT01618799Fasting State · India | 1 | Completed | IPCA Laboratories | May 2012 | 28 |
| NCT01602510Bipolar Disorder · China | 3 | Completed | GlaxoSmithKline | Dec 2015 | 265 |
| NCT01513720Healthy · United States | 1 | Completed | Dr. Reddy's Laboratories | Dec 2002 | 20 |
| NCT01513681Healthy · United States | 1 | Completed | Dr. Reddy's Laboratories | Nov 2002 | 20 |
| NCT01431976Epilepsy · Japan, Korea, Republic of | 3 | Completed | GlaxoSmithKline | Feb 2014 | 20 |
| NCT01431963Epilepsy · Japan, Korea, Republic of | 3 | Completed | GlaxoSmithKline | Mar 2013 | 70 |
| NCT01357902Epilepsy · Hong Kong | 1 | Completed | GlaxoSmithKline | May 23, 2011 | 24 |
| NCT01131975Healthy · United States | 1 | Completed | Dr. Reddy's Laboratories | Feb 2003 | 26 |
| NCT01131949Healthy · United States | 1 | Completed | Dr. Reddy's Laboratories | Feb 2003 | 26 |
| NCT00939614Healthy · India | 1 | Completed | Torrent Pharmaceuticals | ||
| NCT00939458Healthy · India | 1 | Completed | Torrent Pharmaceuticals | ||
| NCT00838279Healthy · Canada | 1 | Completed | Teva Pharmaceutical Industries | Mar 2002 | 32 |
| NCT00838136Healthy · Canada | 1 | Completed | Teva Pharmaceutical Industries | Mar 2002 | 32 |
| NCT00835263Healthy · Canada | 1 | Completed | Teva Pharmaceutical Industries | Feb 2002 | 32 |
| NCT00834561Healthy · Canada | 1 | Completed | Teva Pharmaceutical Industries | Feb 2002 | 32 |
| NCT00723450Bipolar Disorder · United States | 3 | Completed | GlaxoSmithKline | Aug 2013 | 301 |
| NCT00650208Healthy · United States | 1 | Completed | Viatris | Aug 2004 | 27 |
| NCT00647751Healthy · United States | 1 | Completed | Viatris | Aug 2004 | 28 |
| NCT00627575Epilepsy · United States | 1 | Completed | GlaxoSmithKline | Sep 12, 2008 | 119 |
| NCT00605371Epilepsy · United States | 1 | Completed | GlaxoSmithKline | Mar 6, 2008 | 209 |
| NCT00579982Mood Disorders · United States | 3 | Completed | GlaxoSmithKline | Feb 2008 | 97 |
| NCT00566020Bipolar Disorder · Japan | 3 | Completed | GlaxoSmithKline | Oct 2010 | 92 |
| NCT00550407Bipolar Disorder · Japan | 3 | Completed | GlaxoSmithKline | Oct 2009 | 215 |
| NCT00516139Epilepsy · United States | 3 | Completed | GlaxoSmithKline | Jul 2010 | 122 |
| NCT00449774Mental Disorders · United States | 1 | Completed | GlaxoSmithKline | Jun 19, 2007 | 220 |
| NCT00412191Epilepsy · Germany | 1 | Completed | GlaxoSmithKline | Apr 27, 2007 | 180 |
| NCT00395694Epilepsy · Japan | 3 | Completed | GlaxoSmithKline | Mar 1, 2009 | 102 |
| NCT00360126Bipolar Disorder · Australia | 4 | Completed | GlaxoSmithKline | Feb 2007 | 11 |
| NCT00355082Epilepsies, Partial · United States, Argentina, Chile and more | 3 | Completed | GlaxoSmithKline | Nov 2008 | 226 |
| NCT00264615Epilepsy · United States | 3 | Completed | GlaxoSmithKline | Jun 2006 | 45 |
| NCT00224510Bipolar Disorder · Netherlands, Spain | 3 | Completed | GlaxoSmithKline | Sep 2006 | 120 |
| NCT00144872Seizures · United States | 1 | Completed | GlaxoSmithKline | Apr 22, 2006 | 54 |
| NCT00113165Epilepsy · United States, Argentina, Brazil and more | 3 | Completed | GlaxoSmithKline | Jul 2007 | 244 |
| NCT00104416Epilepsy, Tonic-Clonic · United States, Argentina, Brazil and more | 3 | Completed | GlaxoSmithKline | Jul 2008 | 153 |
| NCT00086593Schizophrenia · United States, Canada, United Kingdom | 3 | Completed | GlaxoSmithKline | Jul 2005 | 209 |
| NCT00071747Schizophrenia · United States | 3 | Completed | GlaxoSmithKline | 176 | |
| NCT00067938Bipolar Disorder · United States | 4 | Completed | GlaxoSmithKline | Aug 2004 | 1,200 |
| NCT00056277Bipolar Disorder · United States | 3 | Completed | GlaxoSmithKline | Aug 1, 2005 | 150 |
| NCT00044278Epilepsy · United States, Argentina, Australia and more | 2 | Completed | GlaxoSmithKline | Jun 2006 | 197 |
| NCT00043914Epilepsy | 4 | Completed | GlaxoSmithKline | Jan 29, 2003 | 72 |
| NCT00043901Epilepsy, Tonic-Clonic · United States, Argentina, Chile and more | 4 | Completed | GlaxoSmithKline | Nov 1, 2003 | 141 |
| NCT00043875Epilepsy · United States, Australia, Estonia and more | 2 | Completed | GlaxoSmithKline | Nov 2003 | 177 |
How it is read
Names in the registry
- “Lamotrigine”, 26 entries
- “lamotrigine”, 12 entries
- “Lamotrigine Tablets 25 mg”, 4 entries
- “Lamictal”, 3 entries
- “Lamotrigine 25 mg Chewable Tablets”, 2 entries
Conditions, from the studies’ own filings
- Epilepsy, 17 studies
- Bipolar Disorder, 11 studies
- Epilepsy, Tonic-Clonic, 2 studies
- Epilepsies, Partial, 2 studies
- Schizophrenia, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.